UK BIOBANK LIMITED

Charity overview
Activities - how the charity spends its money
To provide a major genetic resource to assist scientists with research into a variety of diseases and illnesses.
Income and expenditure
Data for financial year ending 30 September 2023
Total income:
£34,535,326
Donations and legacies | £9.14m | |
Charitable activities | £24.81m | |
Other trading activities | £0 | |
Investments | £444.36k | |
Other | £135.22k |
Total expenditure:
£32,137,047
Raising funds | £0 | |
Charitable activities | £32.14m | |
Other | £0 |
£0 investments gains (losses)
Total income includes £13,384,924 from 10 government grant(s)
Charitable expenditure
Charitable expenditure with investment gains
Charitable expenditure
Some charities generate all, or a substantial part, of their income from investments which may have been donated to the charity as endowment or set aside by the charity from its own resources in the past. Such investments usually take the form of stocks and shares but may include other assets, such as property, that are capable of generating income and/or capital growth.
In managing their spending and investments charities need to strike a balance between the needs of future and current beneficiaries. They also need to take account of spending commitments that may stretch over a number of future years. To do this, charities will normally adopt an investment strategy designed to generate both income and capital growth. To maximise returns trustees may commit to investment strategies for several years.
Investments can experience large swings in value so trustees may, in a particular year, decide to realise and spend part of their charity’s capital or to invest part of its income.
By clicking the investment gains checkbox the charitable spending bar is adjusted to take account of capital growth as well as income. This shows the balance the charity is striking, between spending on current beneficiaries and retaining resources for future beneficiaries.
Raising funds and other expenditure | £0 | |
Charitable expenditure | £32.14m | |
Retained for future use | £2.40m |
People

228 Employee(s)
12 Trustee(s)
Employees with total benefits over £60,000
Number of employees | |
---|---|
£60k to £70k | 13 |
£70k to £80k | 4 |
£80k to £90k | 3 |
£90k to £100k | 2 |
£110k to £120k | 1 |
£150k to £200k | 5 |
Fundraising
Trading
Trustee payments
What, who, how, where
- The Advancement Of Health Or Saving Of Lives
- The General Public/mankind
- Sponsors Or Undertakes Research
- Acts As An Umbrella Or Resource Body
- Throughout England And Wales
- Scotland
Governance
- 30 December 2003: Standard registration
No other names
- Bullying and harassment policy and procedures
- Complaints handling
- Complaints policy and procedures
- Conflicting interests
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Investment
- Paying staff
- Risk management
- Safeguarding policy and procedures
- Serious incident reporting policy and procedures
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
Trustees
Trustees are the people responsible for controlling the work, management and administration of the charity on behalf of its beneficiaries. Generally trustees are treasurer, chair, board member etc. The trustees are responsible for keeping this list up to date and can do this by updating their details as they happen through the online service
12 Trustee(s)
Name | Role | Date of appointment | Other trusteeships | Reporting status of other trusteeships | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lord Ajay Kumar Kakkar | Chair | 01 January 2020 |
|
|||||||||||
Professor Melinda Catherine Mills | Trustee | 01 June 2024 |
|
|||||||||||
Dr Claire Fiona Newland | Trustee | 01 May 2024 |
|
|
||||||||||
Dame Professor Clare Gerada | Trustee | 19 January 2024 |
|
|
||||||||||
Bernard Taylor | Trustee | 19 January 2024 |
|
|
||||||||||
Professor Sir Michael Ferguson | Trustee | 01 June 2022 |
|
|
||||||||||
Nicola Perrin | Trustee | 01 June 2022 |
|
|
||||||||||
Dominic Dodd | Trustee | 17 September 2021 |
|
|||||||||||
Tariq Khokhar | Trustee | 17 September 2021 |
|
|||||||||||
Professor Dame Nancy Jane Rothwell | Trustee | 17 September 2021 |
|
|
||||||||||
PROFESSOR ANNEKE LUCASSEN | Trustee | 01 August 2018 |
|
|
||||||||||
PROFESSOR SIR ALEX MARKHAM | Trustee | 24 March 2017 |
|
Financial history
Financial period end date
Income / Expenditure | 30/09/2019 | 30/09/2020 | 30/09/2021 | 30/09/2022 | 30/09/2023 | ||
---|---|---|---|---|---|---|---|
|
Total gross income | £44.72m | £35.19m | £62.73m | £40.64m | £34.54m | |
|
Total expenditure | £42.51m | £39.17m | £63.62m | £38.93m | £32.14m | |
|
Income from government contracts | N/A | N/A | N/A | N/A | N/A | |
|
Income from government grants | N/A | N/A | £325.36k | N/A | £13.38m | |
|
Income - Donations and legacies | £37.49m | £21.48m | £6.62m | £902.48k | £9.14m | |
|
Income - Other trading activities | £4.04m | £3.77m | £10.12m | £7.84m | £0 | |
|
Income - Charitable activities | £2.23m | £2.21m | £2.59m | £2.03m | £24.81m | |
|
Income - Endowments | £0 | £0 | £0 | £0 | £0 | |
|
Income - Investment | £81.97k | £59.80k | £4.79k | £93.31k | £444.36k | |
|
Income - Other | £873.84k | £7.68m | £43.39m | £29.77m | £135.22k | |
|
Income - Legacies | £0 | £0 | £0 | £0 | £0 | |
|
Expenditure - Charitable activities | £37.68m | £28.26m | £31.98m | £24.16m | £32.14m | |
|
Expenditure - Raising funds | £0 | £0 | £0 | £0 | £0 | |
|
Expenditure - Governance | £97.50k | £73.31k | £85.59k | £48.04k | £60.08k | |
|
Expenditure - Grants institution | £0 | £0 | £0 | £0 | £0 | |
|
Expenditure - Investment management | £0 | £0 | £0 | £0 | £0 | |
|
Expenditure - Other | £4.82m | £10.92m | £31.64m | £14.76m | £0 |
Assets and liabilities
Definitions for assets and liabilities
These are assets, other than investments, which are held for more than 12 months and used to run and administer the charity such as buildings, offices, exhibits and fixtures and fittings.
Long term InvestmentsInvestments are assets held by the charity with the sole aim of generating income which will be used for their charitable purposes such as deposit accounts, shares, rental property and unit trusts.
Investment assets are re-valued every year and included in the balance sheet at their current market value.
Long term investments are held for more than 12 months.
These are assets held generally for less than 12 months such as cash and bank balances, debtors, investments to be sold within the coming year and trading stock.
Defined benefit pension scheme asset or liabilityThis is a surplus or deficit in any defined benefit pension scheme operated and represents a potential long-term asset or liability.
Total liabilitiesThese are all the amounts owed by the charity at the balance sheet date to third parties such as bills due but not yet paid, bank overdrafts and loans and mortgages.
Asset / Liability | 30/09/2019 | 30/09/2020 | 30/09/2021 | 30/09/2022 | 30/09/2023 | ||
---|---|---|---|---|---|---|---|
|
Own use assets | £11.94m | £10.62m | £7.69m | £6.76m | £7.08m | |
|
Long-term investments | £0 | £0 | £0 | £0 | £0 | |
|
Other assets | £18.47m | £23.17m | £27.24m | £34.51m | £31.08m | |
|
Defined benefit pension scheme asset or liability | -£1.68m | -£1.77m | -£6.23m | -£5.97m | -£8.04m | |
|
Total liabilities | £12.39m | £19.67m | £17.23m | £22.14m | £27.24m |
Accounts and annual returns
Title | Reporting year | Date received | Received | Download |
---|---|---|---|---|
Annual return | 30 September 2023 | 26 July 2024 | On Time | |
Accounts and TAR | 30 September 2023 | 26 July 2024 | On Time | Download Open in new window |
Annual return | 30 September 2022 | 25 July 2023 | On Time | |
Accounts and TAR | 30 September 2022 | 25 July 2023 | On Time | Download Open in new window |
Annual return | 30 September 2021 | 01 July 2022 | On Time | |
Accounts and TAR | 30 September 2021 | 01 July 2022 | On Time | Download Open in new window |
Annual return | 30 September 2020 | 15 July 2021 | On Time | |
Accounts and TAR | 30 September 2020 | 15 July 2021 | On Time | Download Open in new window |
Annual return | 30 September 2019 | 30 July 2020 | On Time | |
Accounts and TAR | 30 September 2019 | 30 July 2020 | On Time | Download Open in new window |
Governing document
It is not the full text of the charity's governing document.
MEMORANDUM AND ARTICLES INCORPORATED 28/11/2003 AS AMENDED BY SPECIAL RESOLUTION(S) DATED 17/12/2007 AS AMENDED BY SPECIAL RESOLUTION(S) DATED 28/10/2015
Charitable objects
THE OBJECTS FOR WHICH THE COMPANY IS ESTABLISHED ARE TO PROTECT, PRESERVE AND ADVANCE ALL OR ANY ASPECTS OF THE HEALTH AND WELFARE OF HUMAN BEINGS AND TO ADVANCE AND PROMOTE KNOWLEDGE AND EDUCATION BY ENGAGING IN, ENCOURAGING AND SUPPORTING: 1) INVESTIGATIONS INTO THE SEPARATE AND COMBINED EFFECTS OF GENETIC, ENVIRONMENTAL (INCLUDING LIFESTYLE, PHYSIOLOGICAL AND ENVIRONMENTAL EXPOSURES) AND OTHER FACTORS ON HUMAN HEALTH AND WELFARE AND ON THE RISK AND CAUSATION OF DISEASES IN THE HUMAN POPULATION; (2) THE ESTABLISHMENT, HOLDING, OPERATION, MANAGEMENT, PROMOTION, SUPPORT, EXPANSION, IMPROVEMENT AND SAFEGUARDING OF A COLLECTION OF BIOMEDICAL, BIOCHEMICAL, EPIDEMIOLOGICAL, GENETIC AND OTHER DATA AND BLOOD AND OTHER BIOLOGICAL AND BIOCHEMICAL SAMPLES OBTAINED AND DEVELOPED THROUGH, FOR THE PURPOSE OF AND/OR IN CONNECTION WITH SOME OR ALL OF THE INVESTIGATIONS REFERRED TO IN PARAGRAPH (1) AND PERTAINING TO A COHORT OF HUMAN PARTICIPANTS ("DATA AND SAMPLES"), FOR USE IN A RESEARCH, KNOWLEDGE AND INFORMATION RESOURCE PROVISIONALLY KNOWN AS THE UK BIOBANK ("THE RESOURCE"); (3) RESEARCH INTO BIOLOGICAL AND MEDICAL SCIENCES AND OTHER DISCIPLINES WHICH MAY CONTRIBUTE TO THE IMPROVEMENT OF HUMAN HEALTH AND WELFARE ("THE BIOSCIENCES"); (4) THE DISCOVERY, INVENTION, IMPROVEMENT, DEVELOPMENT AND APPLICATION OF TREATMENTS, CURES, DIAGNOSTICS AND OTHER MEDICINAL AGENTS, METHODS AND PROCESSES THAT MAY IN ANY WAY RELIEVE ILLNESS, DISEASE, DISABILITY OR DISORDERS OF WHATEVER NATURE IN HUMAN BEINGS; AND (5) THE STUDY AND UNDERSTANDING OF ANY OF THE BIOSCIENCES.
Area of benefit
NATIONAL
Contact information
- Address:
-
UK Biobank Ltd
Unit 1-2
Spectrum Way
Stockport
SK3 0SA
- Phone:
- 01614755360
- Email:
- enquiries@ukbiobank.ac.uk
Tell us whether you accept cookies
We use cookies to collect information about how you use your Charity Commission Account, such as pages you visit.
We use this information to better understand how you use our website so that we can improve your user experience and present more relevant content.
Thank you for your feedback. Do you have 5 minutes to tell us what you think of this service?Open in new window